Curevac N.V. buy Traumtanz
Start price
15.08.20
/
50%
€68.00
Target price
19.09.20
-
Performance (%)
-35.29%
End price
19.09.20
€44.01
Summary
This prediction ended on 19.09.20 with a price of €44.01. Massive losses of -35.29% were the result for the BUY prediction by Traumtanz. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Curevac N.V. | 5.450% | 5.450% | - | - |
iShares Core DAX® | -1.370% | -3.231% | 11.661% | 16.545% |
iShares Nasdaq 100 | 0.172% | -3.339% | 36.491% | 43.334% |
iShares Nikkei 225® | -0.801% | -7.859% | 18.597% | 4.253% |
iShares S&P 500 | -0.369% | -2.979% | 26.341% | 40.911% |
According to Traumtanz what are the pros and cons of Curevac N.V. for the foreseeable future?
Pros
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
EBIT growth > 30% per year expected
Fair valuation
Standard Investments for future growth
Small cyclical dependencies
Cons
Comments by Traumtanz for this prediction
In the thread Curevac N.V. diskutieren
Buy mit Kursziel 60,0
Kursziel geändert auf 0,0
In the thread Trading Curevac N.v.
Buy beendet
Stopped prediction by Traumtanz for Curevac N.V.
Curevac N.V.
Start price
Target price
Perf. (%)
€72.27
28.11.20
28.11.20
-
28.11.21
28.11.21
51.90%
10.12.20
10.12.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€65.01
14.11.20
14.11.20
-
6.54%
26.11.20
26.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€60.99
13.11.20
13.11.20
€63.00
6.59%
14.11.20
14.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€59.80
13.11.20
13.11.20
€60.00
1.99%
13.11.20
13.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€57.49
12.11.20
12.11.20
€60.00
4.02%
13.11.20
13.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€54.30
12.11.20
12.11.20
€57.00
5.87%
12.11.20
12.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€50.44
10.11.20
10.11.20
€55.00
4.48%
12.11.20
12.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€48.01
10.11.20
10.11.20
€55.00
5.07%
10.11.20
10.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€45.42
16.10.20
16.10.20
€40.00
04.11.21
04.11.21
5.70%
10.11.20
10.11.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation
Curevac N.V.
Start price
Target price
Perf. (%)
€44.88
16.10.20
16.10.20
€40.00
16.10.20
16.10.20
1.20%
16.10.20
16.10.20
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
Leading role in innovation